Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-22-075746
Filing Date
2022-11-29
Accepted
2022-11-29 10:57:47
Documents
2

Document Format Files

Seq Description Document Type Size
1 SOLICITING MATERIAL UNDER 240.14A-12 ea169332-defa14a_pasitheathe.htm DEFA14A 20680
2 GRAPHIC image_001.jpg GRAPHIC 3656
  Complete submission text file 0001213900-22-075746.txt   26791
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40804 | Film No.: 221429461
SIC: 2834 Pharmaceutical Preparations